Ms Anna Middleton
Research Coordinator, Melb Phenotyping Platform
Melbourne School of Psychological Sciences
20 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Safety and pharmacokinetics of sulfasalazine and its metabolite sulfapyridine for treatment of preterm preeclampsia in Australia (SIP): an early phase, unblinded, single-arm, proof of concept clinical trial
DOI: 10.1016/j.eclinm.2026.1037792023
Journal article
Prevalence of Perinatal Anxiety and Related Disorders in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis
DOI: 10.1001/jamanetworkopen.2023.437112023
Journal article
Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management: A Systematic Review and Meta-analysis
DOI: 10.1097/OGX.00000000000012192023
Journal article
PO1_14. CANCELLED: Women’s knowledge of the long-term cardiovascular risks associated with preeclampsia and gestational hypertension: a tertiary patient population survey
DOI: 10.1016/j.preghy.2023.07.0172023
Journal article
Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management: A Systematic Review and Meta-analysis
DOI: 10.1001/jamanetworkopen.2023.131622023
Journal article
Prevalence of Perinatal Depression in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis
DOI: 10.1001/jamapsychiatry.2023.00692023
Journal article
Patients' understanding of long-term cardiovascular risks and associated health-seeking behaviours after pre-eclampsia
DOI: 10.1136/openhrt-2022-002230
RECENT SCHOLARLY WORKS
2022
Journal article
Risk of obstetric anal sphincter injury among women who birth vaginally after a prior caesarean section: A state-wide cohort study
DOI: 10.1111/1471-0528.170632022
Journal article
Developmental Outcomes for Children after Elective Birth at 39 Weeks' Gestation
DOI: 10.1001/jamapediatrics.2022.11652021
Journal article
Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria
DOI: 10.1038/s41598-021-96077-1